1. Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore). 1984. 63:65–81.
2. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol. 1951. 27:277–301.
3. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990. 33:1094–1100.
Article
4. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994. 37:187–192.
5. Gayraud M, Guillevin L, le Toumelin P, Cohen P, Lhote F, Casassus P, et al. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum. 2001. 44:666–675.
Article
6. Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore). 1999. 78:26–37.
Article
7. Kawakami T, Soma Y, Kawasaki K, Kawase A, Mizoguchi M. Initial cutaneous manifestations consistent with mononeuropathy multiplex in Churg-Strauss syndrome. Arch Dermatol. 2005. 141:873–878.
Article
8. Davis MD, Daoud MS, McEvoy MT, Su WP. Cutaneous manifestations of Churg-Strauss syndrome: a clinicopathologic correlation. J Am Acad Dermatol. 1997. 37:199–203.
Article
9. Schwartz RA, Churg J. Churg-Strauss syndrome. Br J Dermatol. 1992. 127:199–204.
Article
10. Im M, Nam YH, Seo YJ, Lee JH, Park JK. A case of Churg-Strauss syndrome showing severe skin necrosis. Korean J Dermatol. 2006. 44:216–219.
11. Lee SW, Park JS, Woo MJ, Kim SW. A case of Churg-Strauss syndrome showing hemorragic bullae. Korean J Dermatol. 2003. 41:1370–1373.
12. Elder DE, Elenitsas R, Johnson BL, Murphy GF, editors. Lever's histopathology of the skin. 2005. 9th ed. Philadelphia: Lippincott Williams & Wilkins;223.
13. Chang SE, Cheong JK, Choi JH, Sung KJ, Moon KC, Koh JK. An unusual case of Churg-Strauss syndrome. Ann Dermatol. 1998. 10:167–171.
Article
14. Termeer CC, Simon JC, Schopf E. Low-dose interferon alfa-2b for the treatment of Churg-Strauss syndrome with prominent skin involvement. Arch Dermatol. 2001. 137:136–138.
15. Guillevin L, Visser H, Noel LH, Pourrat J, Vernier I, Gayraud M, et al. Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome--62 patients. J Rheumatol. 1993. 20:1345–1349.
16. Solans R, Bosch JA, Perez-Bocanegra C, Selva A, Huguet P, Alijotas J, et al. Churg-Strauss syndrome: outcome and long-term follow-up of 32 patients. Rheumatology (Oxford). 2001. 40:763–771.
Article
17. Tervaert JW, Kallenberg CG. Anti-myeloperoxidase antibodies in Churg-Strauss syndrome. J Neurol. 1993. 240:449–450.
Article
18. Assaf C, Mewis G, Orfanos CE, Geilen CC. Churg-Strauss syndrome: successful treatment with mycophenolate mofetil. Br J Dermatol. 2004. 150:598–600.
Article
19. Tang MB, Yosipovitch G. Acute Churg-Strauss syndrome in an asthmatic patient receiving montelukast therapy. Arch Dermatol. 2003. 139:715–718.
Article